WeVote

Bill

Bill

S 1413

Requires health insurance coverage of preimplantation genetic testing with in vitro fertilization under certain conditions.

2024-2025 Regular Session Introduced by Raj Mukherji and 1 co-sponsor

New Jersey bill mandates health insurance coverage of genetic testing for embryos during IVF procedures to reduce treatment costs and increase access to fertility screening options.

Introduced in the Senate, Referred to Senate Commerce Committee
0
WeVote Research Nonpartisan
Bill Summary · S 1413

Legislative bill overview

S 1413 mandates that health insurance plans in New Jersey cover preimplantation genetic testing (PGT) when performed as part of in vitro fertilization (IVF) procedures under specified circumstances. The bill essentially removes cost barriers by requiring insurers to include this genetic screening service in their fertility treatment coverage.

Why is this important

PGT allows couples to screen embryos for genetic disorders and chromosomal abnormalities before implantation, potentially reducing the likelihood of genetic diseases in offspring and improving IVF success rates. However, PGT typically adds $3,000-$5,000 to IVF costs, making this mandate significant for affordability and access to reproductive choices. The policy could expand fertility treatment accessibility for middle-income families while potentially increasing insurance costs overall.

Potential points of contention

  • Religious and ethical concerns: Critics may object on grounds that genetic screening raises questions about embryo selection and aligns with concerns about "designer babies" or conflicts with certain faith-based perspectives on embryo status
  • Insurance cost implications: Mandated coverage increases insurer costs, which may be passed to consumers through higher premiums, affecting those not using fertility services
  • Scope ambiguity: The bill's "certain conditions" language lacks specificity—unclear whether coverage applies to all cases, only when genetic disease history exists, or only for specific disorders, creating implementation uncertainty

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.